Managing Drug-Induced Nephrotoxicity

Course Overview

Course Outline

1. Introduction 
2. Definition 
3. Prevalence 
4. Causes 
5. Nephrotoxic Drugs 
   1. Settings Where Nephrotoxic Drugs are Used 
   2. Clinical Criterium 
   3. Side Effects and Complications 
   4. Drug Costs 
   5. Self-Management 
   6. Poor Access to Care 
6. Special Considerations for Specific Client Populations or Conditions  
   1. Neonatal 
   2. Pediatric and Geriatric 
   3. Pregnancy 
   4. Oncology  
7. Management and Complications 
   1. Telemonitoring in Inpatient and Outpatient Settings 
8. Nursing Considerations 
   1. The Nurse’s Role  
   2. Identifying Drug-Induced Nephrotoxicity 
9. Upcoming Research 
10. Case Study 
11. Conclusion 

Accreditation Statement

Nursing CE Central LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

In this course, we will discuss Managing Drug-Induced Nephrotoxicity​. It will take the average learner 180 minutes to complete and awards 3 contact hours of continuing education.

Course Outcomes

After completing this course, the learner will rate a 4 out of 5 on the Likert Scale for their ability to:

1. Describe common and severe side effects of prescription medications. 
2. Describe educational strategies for the client with nephrotoxicity and their caregivers. 
3. List clinical signs of nephrotoxicity. 
4. Explain management techniques for nephrotoxicity complications. 
5. Discuss recommendations for medication use and nephrotoxicity monitoring in outpatient, non-emergent settings. 

Target Audience

• Registered Nurses (RN)
• Advanced Practice Registered Nurses (APRN)
• Licensed Practical Nurses (LPN/LVN)

Requirement for Completion

1. Enrollment in the course by the learner
2. Read and learn all course materials
3. Complete the course evaluation
4. Attest and testify learning of the course materials

Accreditations + Approvals

Disclosure of Relevant Financial Relationships

Nursing CE Central nor any of the authors, planners, content experts, or any contributors have any relevant financial relationships with ineligible companies to disclose.